Russell Clayton
Hoofd Techniek/Wetenschap/O&O bij LARIMAR THERAPEUTICS, INC.
Vermogen: 142 425 $ op 30-04-2024
Profiel
Russell G.
Clayton is currently the Chief Medical Officer at Larimar Therapeutics, Inc. He previously worked as the Regional Medical Director-Scientific Affairs at Merck & Co., Inc., Director-Asthma Program Division at The Children's Hospital of Philadelphia Foundation, Vice President-Research & Development at Windtree Therapeutics, Inc., and Chief Medical Officer at Alcresta Therapeutics, Inc. He received his undergraduate degree from LaSalle University and his doctorate from Philadelphia College of Osteopathic Medicine.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 17-01-2024 | 22 500 ( 0.04% ) | 142 425 $ | 30-04-2024 |
Actieve functies van Russell Clayton
| Bedrijven | Functie | Begin |
|---|---|---|
| LARIMAR THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 17-07-2023 |
Eerdere bekende functies van Russell Clayton
| Bedrijven | Functie | Einde |
|---|---|---|
Alcresta Therapeutics, Inc.
 Alcresta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Alcresta Therapeutics, Inc. engages in the development of enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare diseases. It offers products designed to improve the delivery, digestion, and absorption of long-chain polyunsaturated fatty acids or LCPUFAs. The company was founded by Robert Gallotto and Dr. Alexey L. Margolin in 2011 and is headquartered in Newton, MA. | Hoofd Techniek/Wetenschap/O&O | 01-04-2017 |
| MERCK & CO., INC. | Hoofd Techniek/Wetenschap/O&O | - |
The Children's Hospital of Philadelphia Foundation
 The Children's Hospital of Philadelphia Foundation Hospital/Nursing ManagementHealth Services The Children's Hospital of Philadelphia Foundation operates charitable organizations for children's health care. It conducts programs on patient care, research, and clinical education. The company was founded in 1855 and is headquartered in Philadelphia, PA. | Corporate Officer/Principal | - |
| WINDTREE THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Russell Clayton
| LaSalle University | Undergraduate Degree |
| Philadelphia College of Osteopathic Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| WINDTREE THERAPEUTICS, INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| LARIMAR THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
The Children's Hospital of Philadelphia Foundation
The Children's Hospital of Philadelphia Foundation Hospital/Nursing ManagementHealth Services The Children's Hospital of Philadelphia Foundation operates charitable organizations for children's health care. It conducts programs on patient care, research, and clinical education. The company was founded in 1855 and is headquartered in Philadelphia, PA. | Health Services |
Alcresta Therapeutics, Inc.
Alcresta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Alcresta Therapeutics, Inc. engages in the development of enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare diseases. It offers products designed to improve the delivery, digestion, and absorption of long-chain polyunsaturated fatty acids or LCPUFAs. The company was founded by Robert Gallotto and Dr. Alexey L. Margolin in 2011 and is headquartered in Newton, MA. | Health Technology |